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Unexpected readmission and mortality after intensive care unit (ICU) 
discharge is a potentially preventable adverse outcome after apparent successful 
treatment of critical illness. Despite significant improvement in overall outcomes of 
critically ill patients in the past two decades, post-ICU readmission and mortality 
rates remain high and exceed 4% in many institutions.[1] Post-ICU readmission and 
mortality are intrinsically interrelated, with a four-fold increase in hospital mortality for 
patients who are readmitted.[2-6] These two adverse outcomes after ICU discharge 
also share similar risk factors, with patients with chronic health conditions and 
unstable physiological parameters at ICU discharge being most vulnerable to these 
adverse events after ICU discharge.[7-8] Although some prognostic scores have 
been shown to predict post-ICU readmission and mortality[9-10], many of these 
scores are difficult to estimate at the bedside, and as such, most practising clinicians 
still rely on subjective assessment of their patients to determine whether their 
patients are suitable for ICU discharge.[11] 
Recurrent or persistent infection and inflammation may play a role in leading 
to unexpected readmission or mortality after ICU discharge. This hypothesis is 
supported by the fact that inflammatory markers such as C-reactive protein (CRP) 
and white blood cell count at ICU discharge were more likely to be elevated among 
those who were subsequently readmitted compared to those without 
readmission.[11-15] Similarly, eosinopenia, a marker of bacterial infection, at ICU 
discharge had also been reported to be more common among those who 
experienced post-ICU readmission or mortality compared to those without such 
adverse events.[16] Procalcitonin (PCT) has a shorter half-life and is more specific in 














been suggested to be useful in guiding when cessation of antibiotic for patients with 
infection.[19-21] Recently, a high PCT concentration at ICU discharge was also 
reported to be associated with an increased risk of unexpected mortality after ICU 
discharge in a small cohort study.[22]  
We hypothesized that an elevated PCT concentration at ICU discharge is a 
reliable predictor for adverse outcomes after ICU discharge, and conducted a cohort 
study to assess whether PCT concentration at ICU discharge is a better predictor for 
post-ICU readmission and mortality than CRP concentrations and eosinopenia. 
Specifically, we assessed whether measuring these inflammatory markers at ICU 
discharge was more predictive of post-ICU readmission or mortality in patients 
admitted to the ICU with an infective cause.  
 
Materials and methods 
This was a single-centred retrospective cohort study. After obtaining approval 
from the Fremantle Hospital Quality and Safety Unit approval, outcome and 
laboratory data of all patients who were admitted to the ICU between April 1, 2012 
and March 31, 2014 were retrieved for this study. Fremantle hospital ICU was a 12-
bed multidisciplinary ICU admitting patients from all medical specialties and most 
surgical specialties, including cardiothoracic surgery. Patients after organ 
transplantation, multiple trauma, neurosurgery and burns were not admitted to this 
ICU. This ICU had a policy of measuring daily PCT concentrations for all patients. 
PCT was measured by BRAHMS PCT ECLIA®; Roche Diagnostics, Switzerland, 
with a normal range <0.05ug/ml. CRP was measured in mg/ml (normal range: 
<1mg/ml). During the study period, patients were discharged from the ICU once the 














discharged by the duty intensivists. No standardized objective criteria including PCT 
concentrations or prognostic scores were used to determine ICU discharge.  
The predictors for adverse events after ICU discharge assessed in this study 
included PCT and CRP concentrations, eosinopenia (or undetectable eosinophil 
count <10/mm3), and white blood cell (WBC) count on the day of ICU admission and 
discharge. Other data that were analysed included demographic factors, severity of 
illness scores including the Simplified Acute Physiology Score (SAPS-2) and Acute 
Physiology and Chronic Health Evaluation (APACHE III) scores, comorbidities, and 
duration of mechanical ventilation and renal replacement. Patients who died in ICU 
or were discharged with a plan to limit life support were excluded from this study. For 
patients who were readmitted to the ICU during the same hospitalization, only the 
data of their first ICU admission were considered. None of the patients were lost to 
follow-up or had missing mortality data. 
 
Statistical analysis 
Continuous and discrete data were presented in median with interquartile 
range (IQR) and count with percentage, respectively. Differences in continuous 
outcomes with skewed distributions and categorical outcomes were analyzed by 
Mann-Whitney and Chi Square tests, respectively. Area under the receiver-
operating-characteristic (ROC) curve was used to determine the ability of different 
predictors in discriminating patients with and without adverse events after ICU 
discharge. As some of these biomarkers may not have a linear association with the 
risk of adverse post-ICU events,[23] the predictive ability of the biomarkers was 
further assessed by analysing them as a categorical variable using the cut-off values 














of >0.70 and >0.80 were considered satisfactory and good, respectively. Multiple 
logistic regression was used to assess whether each predictor was independently 
associated with occurrence of adverse outcome after ICU discharge, after adjusting 
for severity of illness. All analyses were two-tailed and conducted by SPSS for 
Windows (version 22.0, IBM, USA, 2014). A p value <0.05 was taken as significant in 
this study.  
 
Results 
Of the 1877 patients admitted during the study period, 1653 patients (88.1%, 
median age 63 years-old) were discharged from ICU without treatment limitations 
(152 patients died in ICU and 72 patients were discharged from ICU with treatment 
limitation).  A total of 71 patients (4.3%) had unplanned ICU readmission during the 
same hospitalization. Six patients (9%) had culture positive infection as a cause for 
ICU readmission. Twelve (17%) of those readmitted died after readmission 
compared to only six patients died in ward without ICU readmission (0.4%, 
p=0.001)(Figure 1). The median number of days for readmission and hospital 
mortality after first ICU discharge were 4 (IQR 2-9) and 18 (IQR 7-45), respectively. 
In the univariate analyses, severity of acute illness on first presentation to 
ICU, non-elective admission, infection as a cause for admission, chronic renal 
disease (9% vs. 3%), PCT concentrations at ICU discharge (0.6 vs. 0.4ug/L, 
p=0.002) and a high C-reactive protein (CRP) concentration (>100mg/L)(58% vs. 
41%, p=0.004) were associated with an increased risk of post-ICU readmission or 
mortality (Table 1).  
As a continuous predictor, none of the inflammatory markers including PCT 














discriminating between patients with and without post-ICU readmission or mortality 
(Table 2). In the multivariate analysis, only APACHE III score and a CRP 
concentration >100mg/L (odds ratio 1.92, 95% confidence interval 1.12-3.11; 
p=0.008) were significantly associated with an increased risk of post-ICU 
readmission or mortality (Table 3), and this association did not appear to be different 
between patients admitted to ICU with an infection and those admitted with non-
infective causes (Figure 2). 
 
Discussion 
This study showed that as a continuous predictor, none of the inflammatory 
markers at ICU discharge, including PCT concentrations, had enough discrimination 
to be useful in predicting post-ICU readmission or mortality. As a dichotomized 
variable, CRP>100mg/L at ICU discharge was associated with about twice the risk of 
post-ICU readmission or mortality of those with CRP<100mg/L, for both patients 
admitted to ICU due to infective and non-infective causes. These findings have some 
clinical significance and require further consideration. 
First, despite PCT is more specifically associated with infection than CRP or 
WBC count, we could not demonstrate its prognostic significance in predicting 
readmission or mortality after ICU discharge for both patients admitted to ICU with 
infection and other diagnoses. Although PCT concentrations were statistically 
different between those who were readmitted or died after ICU discharge and those 
without such adverse events, the difference was not clinically important nor was its 
area under the ROC curve. This negative finding may be due to the fact that not all 
ICU readmissions or post-ICU deaths are caused by infection. Indeed, we only had 














readmissions, and comorbidities such as chronic renal failure could account for 
some of the adverse events after ICU discharge. Furthermore, because the half-life 
of PCT is short, it may not be useful to predict infection that occurs some days later, 
as in our patients when the median time for ICU readmission was 4 days.  
Second, some previous studies have shown that CRP at ICU discharge may 
be useful in predicting both readmission and unexpected mortality after ICU 
discharge.[11-15] CRP concentrations at ICU discharge in our patients were not as 
useful in predicting adverse events as previously reported. This may be explained by 
a large proportion of elective admissions (42%) with a lower acuity illness compared 
to previous studies. Nevertheless, a substantially elevated CRP concentration 
(>100mg/L) at ICU discharge may still be useful, as an adjunct to other clinical 
assessments, in determining whether the patient is suitable for ICU discharge. The 
association between a high CRP concentration at ICU discharge and post-ICU 
readmission or mortality did not appear to be too different among those admitted to 
ICU with infection or non-infective cause (Figure 2), suggesting that persistent 
inflammation without infection may still be associated with poor patient outcomes 
after ICU discharge. 
The ability of PCT to distinguish between sepsis and inflammation, as well as 
types of sepsis, has recently been challenged. PCT levels seem to be much higher 
in gram negative sepsis compared to gram positive sepsis and may be higher in 
bacterial infections rather than non-bacterial infections.[24] A recent study looking at 
PCT concentrations in acute liver failure patients also found poor correlation 
between sepsis and PCT levels in this type of patients, presumably due to presence 
of extensive inflammation.[25] Regardless, our study attempted to study all ICU 














There are strengths and limitations in this study. As far as we know, this is the 
largest cohort study examining the prognostic value of PCT at ICU discharge for 
patients admitted to ICU with and without infection. We also did not have missing 
mortality data in our patients and have excluded patients who were deemed to be 
not suitable for further life-support treatment or ICU readmission. This is, however, a 
single-centre study and our results may not be generalizable to centres that have 
different case-mix, as well as readmission and post-ICU mortality rates. Finally, 
using PCT and CRP as a guide to confirm resolution of infection with antibiotics has 
been proposed before this study was initiated. Because this was not a blinded study, 
it is possible that some ICU discharge decisions for our patients had been affected 
by the results of the inflammatory markers, potentially reducing their prognostic 
significance. 
In conclusion, after excluding patients who had limitation of life-support order, 
a high CRP concentration (>100mg/L) at ICU discharge was associated with an 
increased risk of unplanned ICU readmission or post-ICU mortality, in both patients 
initially admitted to ICU with infection and non-infective causes. As a continuous or 
dichotomized variable, PCT concentration at ICU discharge was inadequate in its 
predictive ability to guide ICU discharge. More research is needed to assess whether 
other biomarkers are more useful than CRP and PCT in predicting adverse 
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Table 1. Differences in characteristics between patients with and without post-ICU 
readmission or mortality 
 
Variables   Post-ICU readmission or mortality   P value 
 
    Yes (n=77)  No (n=1576) 
 
 
Age, years (IQR)  65 (56-72)  62 (50-73)   0.275 
Male, no. (%)   53 (69)   996 (63)   0.335 
SAPS II score (IQR)  36 (28-51)  29 (21-39)   0.001 
APACHE III score (IQR)  61 (50-85)  49 (36-66)   0.001 
Elective, no. (%)  19 (25)   699 (44)   0.001 
Infection, no. (%)  26 (34)   340 (22)   0.016 
Required CRRT, no. (%) 9 (12)   71 (5)    0.010 
Ventilation days (IQR)  3 (1-5)   1 (1-2)    0.001 
Chronic medical conditions, no. (%): 
- Respiratory  2 (3)   31 (2)    0.664  
- Cardiovascular  4 (5)   58 (4)    0.530 
- Renal   7 (9)   49 (3)    0.013 
- Liver   1 (1)   11 (1)    0.437 
- Diabetes Mellitus 4 (5)   90 (6)    0.999 
- Immunosuppressed  4 (5)   55 (4)    0.351 
Admission PCT (IQR)  0.7 (0.2-10)  0.3 (0.1-2.3)   0.001  
Discharge PCT (IQR)  0.6 (0.3-2.3)  0.4 (0.1-1.2)   0.002 
Discharge PCT >5, no. (%) 10 (13)   185 (12)   0.717 
Admission CRP (IQR)  59 (14-180)  28 (4-120)   0.001  
Discharge CRP (IQR)  120 (63-190)  87 (37-180)   0.014 
Discharge CRP >100, no/ (%) 45 (58)   650 (41)   0.004 
Admission eosinophil (IQR) 0.03 (0.01-0.10) 0.06 (0.02-0.15)  0.003 
Discharge eosinophil (IQR) 0.13 (0.03-0.26) 0.11 (0.03-0.28)  0.734 
Discharge eosinopenia, no. (%) 3 (4)   68 (4)    0.999 
Admission WBC count (IQR) 12 (8-18)  12 (9-17)   0.788 














WBC, white blood cell. CRRT, renal replacement therapy. CRP, C-reactive protein in mg/L. PCT, 
procalcitonin in ug/L. IQR, interquartile range. APACHE, Acute Physiology and Chronic Health 

















Table 2. Area under the receiver-operating-characteristic (ROC) curve for different 
inflammatory markers at ICU discharge in discriminating between patients with and 
without post-ICU readmission or mortality. 
 
Variable      Area under the ROC curve     
      (95% confidence interval) 
    All patients  Infection (+)  Infection (-) 
Discharge PCT   0.61 (0.55-0.66) 0.54 (0.44-0.65) 0.62 (0.55-0.69) 
Discharge CRP  0.58 (0.52-0.64) 0.50 (0.39-0.61) 0.60 (0.53-0.67) 
Discharge eosinophil 0.51 (0.45-0.58) 0.45 (0.35-0.54) 0.53 (0.44-0.61) 
Discharge WBC count 0.53 (0.46-0.61) 0.42 (0.29-0.56) 0.58 (0.50-0.67) 
 

















Table 3. Multivariate analysis showing the association between inflammatory marker 
concentrations at ICU discharge and risk of post-ICU readmission or mortality. 
 
Variables   Odds ratio (95% confidence interval) P value 
APACHE III score  1.02 (1.01-1.03) per score increment 0.001 
Discharge CRP>100mg/L 1.92 (1.18-3.12)    0.008 
Discharge PCT  0.99 (0.98-1.01) per ug/L increment 0.772 
Discharge WBC count 1.01 (0.98-1.05) per x109/L increment 0.457 
Discharge eosinophil  0.99 (0.83-1.19) per x109/L increment 0.965 
 
Classification was correct in 95.1% and the Hosmer Lemeshow chi-square statistic 
for the final model was 11.9 (p=0.157). PCT, procalcitonin. CRP, C-reactive protein. 


















Figure 1. Flow chart showing inclusion and exclusion of patients for the study. 
  
1877 patients (with a total of 
1965 ICU admissions) were 
admitted to the intensive care 





1653 patients (88.1%) 
survived to ICU discharge 
without a plan to limit life 
support treatment 
152 patients (8.1%) died 
in ICU; 72 patients (3.8%) 
survived to ICU discharge 
but with a plan to limit life 
support or ICU 
readmission 





71 patients (4.3%) were 
readmitted to ICU and 12 of 
them died (0.7%) during 
readmission or subsequent to 
second or third ICU discharge 
during the same 
hospitalization 



















Figure 2. A high CRP concentration at intensive care unit (ICU) discharge in relation 
to predicted risk of post-ICU readmission or mortality stratified by infective and non-



















Figure 3. Relationship between risk of post-ICU mortality or readmission and 
procalcitonin (PCT) concentrations at ICU discharge, allowing PCT as a non-linear 
continuous predictor using a restricted cubic spline 3-knot function while adjusting for 
the APACHE III score, white blood cell and eosinophil count and C-reactive protein 
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Figure 4. Relationship between risk of post-ICU mortality or readmission and C-
reactive protein (CRP) concentrations at ICU discharge, allowing CRP as a non-
linear continuous predictor using a restricted cubic spline 3-knot function while 
adjusting for the APACHE III score, white blood cell and eosinophil count, and 
procalcitonin concentration at ICU discharge. Dotted lines indicate 95% confidence 
interval. 
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